Financials
- Market Capitalization 3.82 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1534 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +76.43% | +277.61% | 3.87 B USD | ||
| 1542 | DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | 0.00% | +48.42% | 3.84 B USD | ||
| 1558 | VKTX Viking Therapeutics, Inc. - Common Stock | 32.16 USD | -5.02% | -4.63% | -4.06% | +19.24% | 3.75 B USD | ||
| 1563 | RCUS Arcus Biosciences, Inc. Common Stock | 29.19 USD | -4.61% | -4.30% | +6.46% | +176.42% | 3.72 B USD |